Dust-mite-derived protein disulfide isomerase suppresses airway allergy by inducing tolerogenic dendritic cells

Xiaoyu Liu1, Yuwei Wang1, Desheng Chen1

  • 1State Key Laboratory of Respiratory Disease for Allergy at Shenzhen University, Shenzhen University School of Medicine, Shenzhen, China.

Insights

House dust mite protein PDI induces immune tolerance by promoting regulatory T cells. This protein can alleviate experimental asthma, showing potential for treating immune disorders.

Area of Science:

  • Immunology
  • Allergology
  • Protein biochemistry

Background:

  • House dust mites (HDMs) are common allergens linked to asthma.
  • The immune regulatory functions of HDM-derived proteins are not fully understood.
  • Protein disulfide isomerase (PDI) from HDMs was recently purified.

Purpose of the Study:

  • To investigate the role of HDM-derived PDI in immune regulation.
  • To assess PDI's ability to induce tolerogenic dendritic cells (DCs).
  • To evaluate PDI's therapeutic potential for allergic diseases like asthma.

Main Methods:

  • Mass spectrometry to identify HDM protein complexes with DEC205 on DCs.
  • In vitro human cell culture to assess PDI's effect on DCs and T cells.
  • In vivo murine model to verify findings and test PDI's efficacy in experimental asthma.

Main Results:

  • Over 20 HDM proteins, including PDI, bind to DCs via DEC205-mediated endocytosis.
  • HDM-PDI promotes Foxp3 expression in DCs, leading to tolerogenic DC development.
  • HDM-PDI counteracts Th2 cytokines, restores DC tolerogenicity, and suppresses experimental asthma.

Conclusions:

  • HDM-PDI induces immune tolerance by promoting tolerogenic DCs and regulatory T cells.
  • HDM-PDI administration can alleviate experimental asthma.
  • HDM-PDI shows translational potential for treating immune disorders such as asthma.

Related Concept Videos

Antiasthma Drugs: Mast Cell Stabilizers and Anti-IgE Drugs01:25

Antiasthma Drugs: Mast Cell Stabilizers and Anti-IgE Drugs

Asthma is a chronic respiratory condition for which new therapeutic avenues, including anti-inflammatory drugs like mast cell stabilizers and anti-IgE treatments, continue to be developed.
Mast cell stabilizers, such as cromolyn (also known as sodium cromoglycate) and nedocromil (Tilade), are effective drugs in asthma management. These stabilizers hinder histamine release by skillfully obstructing the activation of mast cells and other cellular entities. Notably, they navigate this task without...
1.5K
Allergic Reactions02:06

Allergic Reactions

Overview
29.9K
Antiasthma Drugs: Leukotriene Modifiers01:19

Antiasthma Drugs: Leukotriene Modifiers

Leukotriene modifiers, or cysteinyl leukotriene receptor antagonists, are medications used to manage chronic asthma. These agents target specific inflammatory mediators produced during arachidonic acid metabolism, an essential process in generating inflammation in the body.
Leukotriene modifiers work through two distinct mechanisms:
1.5K
Asthma: Pathogenesis and Management01:20

Asthma: Pathogenesis and Management

Asthma is a chronic pulmonary condition involving inflammation of the airways, hyper-reactivity, and reversible obstruction of the airways. This condition can significantly impact a person's quality of life, making breathing difficult and leading to distressing symptoms.
Asthma is classified as allergic and non-allergic. Allergens such as dust mites, pollen, and pet dander trigger allergic asthma, while factors like cold air, intense emotions, or exercise can induce non-allergic asthma.
936
Drugs Used in Lower Respiratory Disorders: Overview01:17

Drugs Used in Lower Respiratory Disorders: Overview

Lower respiratory tract disorders present challenges that often require skilled and nuanced approaches for effective management. Common ailments, such as asthma and chronic obstructive pulmonary disease (COPD), have prompted the development of intricate treatment strategies involving bronchodilators and anti-inflammatory drugs, each tailored to ease breathing and revitalize the lungs.
Bronchodilators, the first step of respiration enhancement, come in various forms, each with its own mechanism...
793
Asthma-II: Pathophysiology and Classification01:26

Asthma-II: Pathophysiology and Classification

Asthma is a prevalent chronic respiratory condition marked by inflammation and hyperresponsiveness of the airways. Its pathophysiology involves complex interactions among inflammatory pathways, immune responses, and neural mechanisms.
Additionally, environmental and genetic factors play crucial roles in determining an individual's susceptibility to asthma and the severity of their condition.
Critical processes in asthma pathophysiology include:
3.5K